About: Is there an optimal degree of acid suppression for healing of duodenal ulcers? A model of the relationship between ulcer healing and acid suppression

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Is there an optimal degree of acid suppression for healing of duodenal ulcers? A model of the relationship between ulcer healing and acid suppression Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 01 August 1990

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) наукова стаття, опублікована в серпні 1990 (uk) article scientifique publié en 1990 (fr) im August 1990 veröffentlichter wissenschaftlicher Artikel (de) artículu científicu espublizáu n'agostu de 1990 (ast) scientific article published on 01 August 1990 (en)
publication date	wds:Q68421783-6A8045F8-8F6C-4330-92C9-4A4B73A4ABED
publication date	1990-08-01 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q68421783-1EE99EDE-A1EA-466D-B71C-34EBCD089CA2
language of work or name	English
author name string	wds:Q68421783-6C70EA70-6DFA-40A1-90EB-9F18FD96C959 wds:Q68421783-AA6FFB69-BD62-4506-98E0-65E16EF64B07 wds:Q68421783-F967158D-D538-4474-AE1A-D3D9DFC2F96B
author name string	R H Hunt D W Burget S G Chiverton
rdfs:label	Is there an optimal degree of acid suppression for healing of duodenal ulcers? A model of the relationship between ulcer healing and acid suppression (en) Is there an optimal degree of acid suppression for healing of duodenal ulcers? A model of the relationship between ulcer healing and acid suppression (nl)
skos:prefLabel	Is there an optimal degree of acid suppression for healing of duodenal ulcers? A model of the relationship between ulcer healing and acid suppression (en) Is there an optimal degree of acid suppression for healing of duodenal ulcers? A model of the relationship between ulcer healing and acid suppression (nl)
name	Is there an optimal degree of acid suppression for healing of duodenal ulcers? A model of the relationship between ulcer healing and acid suppression (en) Is there an optimal degree of acid suppression for healing of duodenal ulcers? A model of the relationship between ulcer healing and acid suppression (nl)
title	wds:Q68421783-126E4FC5-B7E4-481A-AD91-BCA1B70590F8
title	Is there an optimal degree of acid suppression for healing of duodenal ulcers? A model of the relationship between ulcer healing and acid suppression (en)
page(s)	wds:Q68421783-C2432CE3-3CAA-4ED9-A4C6-F335FDA979F5
page(s)	345-351
instance of	wds:Q68421783-A7AC59FF-0A3F-4442-A73D-5FA1C2C8F36A wds:Q68421783-fbfb3933-7961-443a-ab82-af109e9c7ef4
instance of	meta-analysis scholarly article
PubMed ID	wds:Q68421783-1FCA93CF-6FFB-4183-905D-94E8BAC98AE0
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/2142113
PubMed ID	2142113
published in	wds:Q68421783-285AEA40-9BAB-4F70-9C82-78314C22DE82
published in	Gastroenterology
issue	wds:Q68421783-01DE0DF6-570E-4360-ADA7-A9861DD02F9C
volume	wds:Q68421783-34672D3B-8B0C-49C4-9E42-36A5855F9CBC
issue	2
volume	99
DOI	wds:Q68421783-2C4EFE0A-68ED-447F-BEFA-FB942E59AF68
DOI	http://dx.doi.org/10.1016/0016-5085(90)91015-X
DOI	10.1016/0016-5085(90)91015-X
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q68421783
is cites work of	Acid suppression: Optimizing therapy for gastroduodenal ulcer healing, gastroesophageal reflux disease, and stress-related erosive syndrome Predictable prolonged suppression of gastric acidity with a novel proton pump inhibitor, AGN 201904-Z. Omeprazole. An update of its pharmacology and therapeutic use in acid-related disorders Acid peptic diseases: pharmacological approach to treatment Histological esophagitis: clinical and histological response to omeprazole in children The proton-pump inhibitors: similarities and differences Pharmacodynamic evaluation of intragastric pH and implications for famotidine dosing in the prophylaxis of non-steroidal anti-inflammatory drug induced gastropathy-a proof of concept analysis. Effect of curing Helicobacter pylori infection on intragastric pH during treatment with omeprazole Variability in individual response to various doses of omeprazole A review of rabeprazole in the treatment of acid-related diseases Proton pump inhibitors: do differences in pharmacokinetics translate into differences in clinical outcomes? Progress with proton pump inhibition A proton-pump inhibitor expedition: the case histories of omeprazole and esomeprazole Antacids revisited: a review of their clinical pharmacology and recommended therapeutic use. Effects of single doses of rabeprazole 20 mg and esomeprazole 40 mg on 24-h intragastric pH in healthy subjects Eradication of Helicobacter pylori infection Antimicrobial therapy of peptic ulcers Is the Time of Dosing of a Potent Long-Acting H2-Receptor Antagonist Critical? Twenty-Four-Hour pH Measurements with SKF-94482 The anti-secretory and anti-ulcer activities of esomeprazole in comparison with omeprazole in the stomach of rats and rabbits Pathophysiological effects of long-term acid suppression in man. Role of gastric acid suppression in the treatment of gastro-oesophageal reflux disease Acid peptic disease in the elderly Risk-benefit assessment of omeprazole in the treatment of gastrointestinal disorders Problems with the interpretation of gastric pH measurement What is potent acid inhibition, and how can it be achieved? Helicobacter pylori and NSAIDs--the end of the debate? Changes in nocturnal and peak acid outputs after duodenal ulcer healing with sucralfate or ranitidine The long-lasting effect of TU-199, a novel H+, K(+)-ATPase inhibitor, on gastric acid secretion in dogs Oral esomeprazole vs. intravenous pantoprazole: a comparison of the effect on intragastric pH in healthy subjects Effect of omeprazole in the treatment of refractory acid-related diseases in childhood: endoscopic healing and twenty-four-hour intragastric acidity Gastric secretion and peptic ulceration in cirrhosis pH, healing rate, and symptom relief in patients with GERD. Comparison of the effect on intragastric pH of a single dose of omeprazole or rabeprazole: which is suitable for on-demand therapy? Comparison of the efficacy of rabeprazole 10 mg and omeprazole 20 mg for the healing rapidity of peptic ulcer diseases. Comparison of the effects of single and repeated oral doses of lansoprazole and rabeprazole on ambulatory 24-hour intragastric pH in healthy volunteers Relative potency of proton-pump inhibitors-comparison of effects on intragastric pH. Effect of nizatidine 300 mg at night and omeprazole 20 mg in the morning on 24-hour intragastric pH and bacterial overgrowth in patients with acute duodenal ulcer Histamine H2-receptor antagonists in peptic ulcer disease. Efficacy in healing peptic ulcers Tolerance and rebound to H2-receptor antagonists: Intragastric acidity in patients with duodenal ulcer SK&F 96067 is a reversible, lumenally acting inhibitor of the gastric (H+ + K+)-ATPase Comparison of five antisecretory agents acting via gastric H+/K+-ATPase Optimizing acid suppression for treatment of acid-related diseases Acid-suppressive efficacy of a reduced dosage of rabeprazole: comparison of 10 mg twice daily rabeprazole with 20 mg twice daily rabeprazole, 30 mg twice daily lansoprazole, and 20 mg twice daily omeprazole by 24-hr intragastric pH-metry Acid, protons and Helicobacter pylori. Medium- and high-dose omeprazole plus amoxicillin for eradication of Helicobacter pylori in duodenal ulcer disease Age-dependent eradication of Helicobacter pylori with dual therapy Medical management of gastrinoma in a cat. 1976 and all that!--20 years of antisecretory therapy The effect of GR122311X, a bismuth compound with H2-antagonist activity, on 24-hour intragastric acidity U.S. experience with omeprazole in duodenal ulcer. Multicenter double-blind comparative study with ranitidine. The Omeprazole DU Comparative Study Group Tolerance to oral H2-receptor antagonists A comparison of roxatidine and ranitidine for the acute treatment of duodenal ulcer Are the orally administered proton pump inhibitors equivalent? A comparison of lansoprazole, omeprazole, pantoprazole, and rabeprazole ACVIM consensus statement: Support for rational administration of gastrointestinal protectants to dogs and cats Physiology of the parietal cell and therapeutic implications Gastric acid secretion: activation and inhibition.

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 176 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software